Pages that link to "Q36443608"
Jump to navigation
Jump to search
The following pages link to D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect (Q36443608):
Displaying 50 items.
- Plant D-2-hydroxyglutarate dehydrogenase participates in the catabolism of lysine especially during senescence (Q24632201) (← links)
- Two D-2-hydroxy-acid dehydrogenases in Arabidopsis thaliana with catalytic capacities to participate in the last reactions of the methylglyoxal and beta-oxidation pathways (Q24657448) (← links)
- Mitochondrial metabolic remodeling in response to genetic and environmental perturbations (Q26747718) (← links)
- Genetically-defined metabolic reprogramming in cancer (Q27004739) (← links)
- The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases (Q27667409) (← links)
- IDH mutations in tumorigenesis and their potential role as novel therapeutic targets (Q27692015) (← links)
- Metabolic consequences of oncogenic IDH mutations (Q28082949) (← links)
- Inhibition of 2-oxoglutarate dependent oxygenases (Q28306956) (← links)
- Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development (Q33387965) (← links)
- Oncometabolites: linking altered metabolism with cancer (Q34368256) (← links)
- The redox basis of epigenetic modifications: from mechanisms to functional consequences. (Q35055739) (← links)
- D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2 (Q35889016) (← links)
- Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation (Q36401831) (← links)
- What do we know about IDH1/2 mutations so far, and how do we use it? (Q36788229) (← links)
- Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency (Q37133507) (← links)
- Membrane translocation of glutaric acid and its derivatives (Q37135482) (← links)
- Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? (Q37715518) (← links)
- IDH mutations in glioma and acute myeloid leukemia (Q37778541) (← links)
- Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies (Q37830368) (← links)
- Metabolic and monogenic causes of seizures in neonates and young infants (Q37916952) (← links)
- IDH mutations in human glioma (Q38022856) (← links)
- IDH mutations in acute myeloid leukemia (Q38037202) (← links)
- Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities (Q38116645) (← links)
- The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms (Q38121089) (← links)
- ω-Amidase: an underappreciated, but important enzyme in L-glutamine and L-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases. (Q38563900) (← links)
- HOT mutation screening in human glioblastomas (Q38747962) (← links)
- Expression of R132H mutational IDH1 in human U87 glioblastoma cells affects the SREBP1a pathway and induces cellular proliferation (Q39271419) (← links)
- Organic anion transporters OAT1 and OAT4 mediate the high affinity transport of glutarate derivatives accumulating in patients with glutaric acidurias (Q39998695) (← links)
- The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites (Q41037176) (← links)
- Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling. (Q41106998) (← links)
- Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations (Q42141882) (← links)
- The sodium-dependent di- and tricarboxylate transporter, NaCT, is not responsible for the uptake of D-, L-2-hydroxyglutarate and 3-hydroxyglutarate into neurons (Q42204137) (← links)
- Metabolic syndromes and malignant transformation: where the twain shall meet (Q42852502) (← links)
- IDH1 mutations in gliomas: when an enzyme loses its grip (Q43175207) (← links)
- Interconversion of 2-oxoglutarate and 2-hydroxyglutarate (Q45317373) (← links)
- Exonic mutations in the L2HGDH gene in Staffordshire bull terriers. (Q45574197) (← links)
- Peripheral neuropathy in a patient with D-2-hydroxyglutaric aciduria (Q46147032) (← links)
- Catabolism of GABA, succinic semialdehyde or gamma-hydroxybutyrate through the GABA shunt impair mitochondrial substrate-level phosphorylation (Q48260832) (← links)
- Metaphyseal chondromatosis combined with D-2-hydroxyglutaric aciduria in four patients (Q48492177) (← links)
- IDH1 mutations in grade II astrocytomas are associated with unfavorable progression‐free survival and prolonged postrecurrence survival (Q49109048) (← links)
- Isocitrate dehydrogenase 1/2 mutational analyses and 2‐hydroxyglutarate measurements in Wilms tumors (Q54393106) (← links)
- Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2 (Q57657555) (← links)
- Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas (Q58766030) (← links)
- Neurological manifestations of organic acidurias. (Q64971283) (← links)
- Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate (Q82467819) (← links)
- Co-morbidity of Sanfilippo syndrome type C and D-2-hydroxyglutaric aciduria (Q83559084) (← links)
- Measurement of Oncometabolites D-2-Hydroxyglutaric Acid and L-2-Hydroxyglutaric Acid (Q88584070) (← links)
- Neuroimaging Findings of Organic Acidemias and Aminoacidopathies (Q88662776) (← links)
- MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome (Q89893236) (← links)
- Friend or foe-IDH1 mutations in glioma 10 years on (Q90025515) (← links)